Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut-71526, Egypt.
Acta Pharm. 2009 Dec;59(4):365-82. doi: 10.2478/v10007-009-0033-8.
5-Acyl-8-hydroxyquinoline-2-(3'-substituted-4'-aryl-2,3-dihydrothiazol-2'-ylidene)hydrazones, 5a-e to 10a-c, were prepared by the reaction of appropriate 5-acyl-8-hydroxyquinoline-4-substituted thiosemicarbazones 3a-e and phenacyl bromides 4a-e. Structures of the new compounds were verified on the basis of spectral and elemental analyses. Twenty-eight new compounds were tested for their possible antimicrobial activities. Most of the tested compounds showed weak to moderate antibacterial activity against most of the bacterial strains used in comparison with gatifloxacin as a reference drug. The test compounds showed weak to moderate antifungal activity against tested fungi in comparison with ketoconazole as a reference drug. On the other hand, the newly synthesized compounds were tested for their anti-inflammatory effects and most of them showed good to excellent anti-inflammatory activity compared to indomethacin. Moreover, ulcerogenicity and the median lethal dose (LD(50)) of the most active anti-inflammatory compounds 6b and 9e were determined in mice; they were non-toxic at doses up to 400 mg kg(-1) after i.p. administration.
5-酰基-8-羟基喹啉-2-(3'-取代-4'-芳基-2,3-二氢噻唑-2'-亚基)腙,5a-e 至 10a-c,是通过适当的 5-酰基-8-羟基喹啉-4-取代的硫代半卡巴腙 3a-e 与苯甲酰溴 4a-e 反应制备的。新化合物的结构是基于光谱和元素分析来验证的。测试了 28 种新化合物的可能抗菌活性。与加替沙星作为参比药物相比,大多数测试化合物对大多数测试的细菌菌株具有弱至中等的抗菌活性。与酮康唑作为参比药物相比,测试化合物对测试真菌具有弱至中等的抗真菌活性。另一方面,新合成的化合物被测试其抗炎作用,其中大多数与吲哚美辛相比表现出良好至优异的抗炎活性。此外,在小鼠中测定了最具抗炎活性的化合物 6b 和 9e 的致溃疡性和半数致死剂量 (LD(50));它们在腹腔内给药高达 400 mg kg(-1) 时没有毒性。